|
KMID : 1144320160480040267
|
|
감염과 화학요법
2016 Volume.48 No. 4 p.267 ~ p.273
|
|
|
Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
|
|
Choo Eun-Ju
Chambers Henry F.
|
|
|
Abstract
|
|
|
|
Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of health care-associated infections. Vancomycin remains an acceptable treatment option. There has been a welcome increase in the number of agents available for the treatment of MRSA infection. These drugs have certain differentiating attributes and may offer some advantages over vancomycin, but they also have significant limitations. These agents provide some alternative when no other options are available.
|
|
|
KEYWORD
|
|
|
Methicillin-resistant Staphylcoccus aureus, Vancomycin, Treatment
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|